Cargando…

Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?

OBJECTIVE: Among patients with a history of ESBL infection, uncertainty remains regarding whether all of these patients require ESBL-targeted therapy when presenting with a subsequent infection. We sought to determine the risks associated with a subsequent ESBL infection to help inform empiric antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Tyler J., DeWitt, Michael, Johnson, James W., Beardsley, James R., Munawar, Iqra, Palavecino, Elizabeth, Luther, Vera P., Ohl, Christopher A., Williamson, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031583/
https://www.ncbi.nlm.nih.gov/pubmed/36970424
http://dx.doi.org/10.1017/ash.2022.363
_version_ 1784910637074219008
author Stone, Tyler J.
DeWitt, Michael
Johnson, James W.
Beardsley, James R.
Munawar, Iqra
Palavecino, Elizabeth
Luther, Vera P.
Ohl, Christopher A.
Williamson, John C.
author_facet Stone, Tyler J.
DeWitt, Michael
Johnson, James W.
Beardsley, James R.
Munawar, Iqra
Palavecino, Elizabeth
Luther, Vera P.
Ohl, Christopher A.
Williamson, John C.
author_sort Stone, Tyler J.
collection PubMed
description OBJECTIVE: Among patients with a history of ESBL infection, uncertainty remains regarding whether all of these patients require ESBL-targeted therapy when presenting with a subsequent infection. We sought to determine the risks associated with a subsequent ESBL infection to help inform empiric antibiotic decisions. METHODS: A retrospective cohort study of adult patients with positive index culture for Escherichia coli or Klebsiella pneumoniae (EC/KP) receiving medical care during 2017 was conducted. Risk assessments were performed to identify factors associated with subsequent infection caused by ESBL-producing EC/KP. RESULTS: In total, 200 patients were included in the cohort, 100 with ESBL-producing EC/KP and 100 with ESBL-negative EC/KP. Of 100 patients (50%) who developed a subsequent infection, 22 infections were ESBL-producing EC/KP, 43 were other bacteria, and 35 had no or negative cultures. Subsequent infection caused by ESBL-producing EC/KP only occurred when the index culture was also ESBL-producing (22 vs 0). Among those with ESBL-producing index culture, the incidences of subsequent infection caused by ESBL-producing EC/KP versus other bacterial subsequent infection were similar (22 vs 18; P = .428). Factors associated with subsequent infection caused by ESBL-producing EC/KP include history of ESBL-producing index culture, time ≤180 days between index culture and subsequent infection, male sex, and Charlson comorbidity index score >3. CONCLUSIONS: History of ESBL-producing EC/KP culture is associated with subsequent infection caused by ESBL-producing EC/KP, particularly within 180 days after the historical culture. Among patients presenting with infection and a history of ESBL-producing EC/KP, other factors should be considered in making empiric antibiotic decisions, and ESBL-targeted therapy may not always be warranted.
format Online
Article
Text
id pubmed-10031583
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-100315832023-03-23 Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed? Stone, Tyler J. DeWitt, Michael Johnson, James W. Beardsley, James R. Munawar, Iqra Palavecino, Elizabeth Luther, Vera P. Ohl, Christopher A. Williamson, John C. Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVE: Among patients with a history of ESBL infection, uncertainty remains regarding whether all of these patients require ESBL-targeted therapy when presenting with a subsequent infection. We sought to determine the risks associated with a subsequent ESBL infection to help inform empiric antibiotic decisions. METHODS: A retrospective cohort study of adult patients with positive index culture for Escherichia coli or Klebsiella pneumoniae (EC/KP) receiving medical care during 2017 was conducted. Risk assessments were performed to identify factors associated with subsequent infection caused by ESBL-producing EC/KP. RESULTS: In total, 200 patients were included in the cohort, 100 with ESBL-producing EC/KP and 100 with ESBL-negative EC/KP. Of 100 patients (50%) who developed a subsequent infection, 22 infections were ESBL-producing EC/KP, 43 were other bacteria, and 35 had no or negative cultures. Subsequent infection caused by ESBL-producing EC/KP only occurred when the index culture was also ESBL-producing (22 vs 0). Among those with ESBL-producing index culture, the incidences of subsequent infection caused by ESBL-producing EC/KP versus other bacterial subsequent infection were similar (22 vs 18; P = .428). Factors associated with subsequent infection caused by ESBL-producing EC/KP include history of ESBL-producing index culture, time ≤180 days between index culture and subsequent infection, male sex, and Charlson comorbidity index score >3. CONCLUSIONS: History of ESBL-producing EC/KP culture is associated with subsequent infection caused by ESBL-producing EC/KP, particularly within 180 days after the historical culture. Among patients presenting with infection and a history of ESBL-producing EC/KP, other factors should be considered in making empiric antibiotic decisions, and ESBL-targeted therapy may not always be warranted. Cambridge University Press 2023-03-08 /pmc/articles/PMC10031583/ /pubmed/36970424 http://dx.doi.org/10.1017/ash.2022.363 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Original Article
Stone, Tyler J.
DeWitt, Michael
Johnson, James W.
Beardsley, James R.
Munawar, Iqra
Palavecino, Elizabeth
Luther, Vera P.
Ohl, Christopher A.
Williamson, John C.
Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
title Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
title_full Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
title_fullStr Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
title_full_unstemmed Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
title_short Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
title_sort analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (esbl)–producing escherichia coli or klebsiella pneumoniae: is esbl-targeted therapy always needed?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031583/
https://www.ncbi.nlm.nih.gov/pubmed/36970424
http://dx.doi.org/10.1017/ash.2022.363
work_keys_str_mv AT stonetylerj analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT dewittmichael analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT johnsonjamesw analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT beardsleyjamesr analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT munawariqra analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT palavecinoelizabeth analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT lutherverap analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT ohlchristophera analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded
AT williamsonjohnc analysisofinfectionsamongpatientswithhistoricalculturepositiveforextendedspectrumbetalactamaseesblproducingescherichiacoliorklebsiellapneumoniaeisesbltargetedtherapyalwaysneeded